Skip to main content
. 2020 Aug 21;22:263–272. doi: 10.1016/j.omtn.2020.08.019

Table 1.

Characteristics of Induced Dystrophin Isoforms

Dystrophin Isoforms Skipped Exons Dystrophin Protein Level Dystrophin Immunofluorescent Intensity β-Dystroglycan Immunofluorescent Intensity Centrally Nucleated Fibers (Total Fibers Counted) Fibrosis Muscle Pathology
C57

Sham-treated N.A 100% 100% 100% 0 (538) 36.10%
Del23 23 96.7% 76.7% 88.4% 1.79% (502) 54.98% +
Del56/57 56+57 82.3% 77.4% 81.0% 1.84% (489) 51.33% +
Del58/59 58+59 27.5% 48.5% 71.3% 25.75% (532) 80.99% + + + +
Del70 70 31.8% 44.1% 57.4% 26.85% (517) 85.41% + + + +

mdx

Sham-treated N.A 0 30.2% 56.1% 28.14% (501) 100% + + + + +
Del23 23 81.4% 79.2% 78.0% 6.12% (555) 63.59% + +
Del23/56/57 23+56+57 67.5% 77.3% 74.5% 4.60% (717) 59.9% + +
Del23/58/59 23+58+59 22.3% 44.4% 59.9% 19.20% (552) 88.97% + + + +
Del23/70 23+70 10.1% 35.8% 58.2% 23% (500) 81.21% + + + +

Dystrophin protein level was measured by densitometry and compared to sham-treated C57 (set as 100%) and sham-treated mdx mice (set as 0). Mean immunofluorescent intensity was measured by ImageJ to show the expression level of the dystrophin and β-dystroglycan; immunofluorescence intensity was normalized to sham-treated C57. Total muscle fibers and central nucleated fibers were counted and the percentage of fibers with central nucleation was shown. The degree of fibrosis was determined by ImageJ measuring the intensity of collagen-rich fibrotic regions in blue and was normalized to sham-treated mdx; “+” indicates the severity of muscle pathology; “+ + + + +” indicates the most severe pathology; “–” indicates negative; Del: deletion; N.A., not applicable.